Screener
Beta Bionics BBNX Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Beta Bionics in its filing.
Tagged under the XBRL concept us-gaap:CommonStockValue.
The source filing: Beta Bionics’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:20 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-323777
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Commitments and contingencies (Note 15) | ||
| Stockholders’ equity: | ||
| Preferred stock, $0.0001 par value, 10,000,000 shares authorized; no shares issued and outstanding at June 30, 2026 and December 31, 2025 | — | — |
| Common stock, $0.0001 par value, 700,000,000 shares authorized; 44,981,606 and 44,360,873 issued and outstanding at June 30, 2026 and December 31, 2025, respectively | 5 | 4 |
| Additional paid-in capital | 671,986 | 657,140 |
| Accumulated other comprehensive income (loss) | (390) | 403 |
| Accumulated deficit | (415,235) | (369,937) |
| Total stockholders’ equity | 256,366 | 287,610 |
Item 1. Financial Statements.
FAQ
- What is Beta Bionics's common stock?
- Beta Bionics (BBNX) reported common stock of $5K in Q2 2026.
- How has Beta Bionics's common stock changed year-over-year?
- Beta Bionics's common stock increased by 25.0% year-over-year, from $4K to $5K.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).
Ask your AI about Beta Bionics's common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude